ICD-10-CM Billable Code

C44.692

Other specified malignant neoplasm of skin of right upper limb, including shoulder

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code C44.692 refers to a specific type of skin cancer located on the right upper limb, including the shoulder. This classification is used by healthcare professionals to identify and document cases of malignant skin growths that do not fit into more common categories. Being aware of this diagnosis allows for appropriate medical management and treatment planning. Skin cancers are among the most common types of cancers worldwide, and early detection is crucial for effective treatment. This resource offers an overview of what this diagnosis entails, causes, symptoms, ways it is diagnosed, and general treatment considerations.

Causes & Symptoms

Clinical Causes: Prolonged exposure to ultraviolet (UV) rays from the sun or tanning beds. Lighter skin pigmentation, which offers less natural protection from UV rays. History of sunburns or excessive sun exposure over time. Presence of certain skin conditions or precancerous lesions like actinic keratosis. Weakened immune system due to conditions like HIV/AIDS or immunosuppressive medications. Age, as risk increases with advancing age. Genetic predisposition, including inherited skin cancer syndromes. Exposure to carcinogenic chemicals or substances.

Key Symptoms: Persistent skin lesions or growths that do not heal. New nodule or lump on the skin that may be red, pink, or flesh-colored. Changes in the appearance of a mole or pigmented spot, such as asymmetry, irregular borders, or color variation. Open sore or ulcer that does not heal and may bleed or crust. Thickened or raised areas of skin or plaques. Sensation of pain, tenderness, or itching in the affected area. Swelling or enlarged lymph nodes near the site of the lesion.

Diagnostic & Treatment

Diagnosis Path: Diagnosing a malignant skin neoplasm typically involves a combination of physical examination and diagnostic procedures. A healthcare provider will first examine the skin for suspicious lesions, noting their size, shape, and color. A biopsy is often performed, where a small sample of tissue from the lesion is removed and examined microscopically for cancer cells. Additional imaging tests, such as ultrasound or MRI, may be used to assess the extent of the disease, especially if there is concern about spread to surrounding tissues or lymph nodes. The diagnosis stage helps guide appropriate treatment strategies.

Treatment Protocols: Treatment options for malignant skin neoplasms depend on the type, size, location, and stage of the tumor. Common approaches include: - Surgical excision to remove the tumor completely. - Mohs micrographic surgery, especially for lesions on the face or complicated areas. - Radiation therapy to target residual cancer cells or in cases where surgery isn’t suitable. - Systemic therapies like targeted therapy or immunotherapy for advanced cases. - Regular follow-up and skin examinations post-treatment to monitor for recurrence or new skin cancers. Early diagnosis and appropriate treatment are essential to improve outcomes and reduce the risk of metastasis and further complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.692 a billable ICD-10 code?
Yes, C44.692 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.692?
Clinical documentation must specify the nature of Other specified malignant neoplasm of skin of right upper limb, including shoulder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference